Pilot Study of Nelarabine in Combination With Intensive Chemotherapy in High-Risk T-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

PURPOSE: Children's Oncology Group study AALL00P2 was designed to assess the feasibility and safety of adding nelarabine to a BFM 86–based chemotherapy regimen in children with newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL). PATIENTS AND METHODS: In stage one of the study, eight pa...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Dunsmore, Kimberly P., Devidas, Meenakshi, Linda, Stephen B., Borowitz, Michael J., Winick, Naomi, Hunger, Stephen P., Carroll, William L., Camitta, Bruce M.
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2012
Sujets:
Original Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3402886/
https://ncbi.nlm.nih.gov/pubmed/22734022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.40.8724
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires